Page 18 - Latest Updates on Trump tariffs

Pfizer's drug-price deal with Trump follows months of negotiation deadlock

Pfizer and the White House were deadlocked for months over lowering US drug prices, with Trump demanding quick results from drug executives right from the start of his second term

Putin orders steps to ease India-Russia trade imbalance amid Trump tariffs

Criticising US pressure on India and China to cut energy ties with Moscow, Putin said Trump's tariffs could backfire and pledged to reduce trade imbalance with New Delhi

Trump admin puts 100% pharma tariffs on hold but uncertainty looms

The Trump administration has clarified that while these tariffs might not be enforced immediately, they are still in play and can be implemented in the near future

'Dependence must not turn into compulsion': Mohan Bhagwat amid US tariffs

RSS Vijayadashami event: Mohan Bhagwat urges India to focus on self-reliance, stay alert to security threats and honour past sacrifices

RBI unveils measures to support exporters amid 50% US tariff impact

The Reserve Bank on Wednesday announced a host of measures to help exporters tide over challenges posed by the imposition of 50 per cent tariffs by the US administration on Indian shipments. The measures include reduced paperwork and compliance burden for small exporters and importers. "The export sector is a vital part of India's economy," said RBI Governor Sanjay Malhotra, while announcing steps to further strengthen the sector and enhance ease of doing business for traders. One of the key measures is the extension of the time period for repatriation from foreign currency accounts of Indian exporters in IFSC, from one month to three months. In January 2025, the RBI had permitted Indian exporters to open foreign currency accounts with a bank outside India for the realisation of export proceeds. Funds in these accounts can be used for making import payments or have to be repatriated by the end of next month from the date of receipt of the funds. "It has now been decided to extend

India manufacturing PMI eases to 57.7 in Sep, selling prices hit 12-yr high

The September manufacturing PMI reading marked the weakest improvement in sector health since May, though it remained well above the neutral 50 threshold

Others exploited US for years, tariffs now ensure fair treatment: Trump

"I love tariffs. Most beautiful word... Tariff is my favourite word... We're becoming rich as hell...," said US President Donald Trump

Trump sets new tariffs on lumber, wood products in bid to boost US industry

Trump said the planned actions will 'strengthen supply chains, bolster industrial resilience, create high-quality jobs and increase domestic capacity utilization for wood products'

Stock Market Close: Sensex dips 97 pts, logs 8th straight loss ahead of RBI policy; Nifty at 24,611

Sensex Today| Stock Market Close Highlights today, Sep 30: In the broader market, Nifty MidCap 100 index closed lower by 0.01 per cent, while NIfty SmallCap was up 0.08 per cent.

Foreign investors exit Indian stocks at record pace amid tariff woes

Overseas investors have pulled a net $16.8 billion from local shares this year through Sept. 26, nearing the record set in 2022

Indian economy to grow at 6.5% in FY26, US tariffs to weigh on exports: ADB

Despite a strong 7.8 per cent growth in the first quarter, the Indian economy is expected to grow at 6.5 per cent in the current financial year as the impact of US tariffs on Indian exports will reduce prospects, particularly in the second half, ADB said on Tuesday. It is to be noted that the Asian Development Outlook (ADO) of the Asian Development Bank (ADB), released in April, had projected a higher growth rate of 7 per cent, which was lowered to 6.5 per cent in the July report on concern of a steep 50 per cent US tariffs on shipment from India. While GDP grew strongly in the first quarter (Q1) of FY26 at 7.8 per cent on improved consumption and government spending, additional US tariffs on Indian exports will reduce growth, particularly in the second half of FY26 and in FY27, though resilient domestic demand and service exports will cushion the impact, ADO September 2025 said. The reduction in exports will impact India's GDP in both FY26 and FY27 as the tariffs are implemented. A

US President Donald Trump announces 100% levies on foreign-made films

US tariffs may script huge setback for Indian films; industry's revenue from US may take 30-40% hit

Stock Market Close Highlights: Sensex, Nifty flat; oil & gas, PSB stocks gain

Stock Market Close Highlights, Sep 29: In the broader market, Nifty MidCap 100 index ended 0.27 per cent higher, while Nifty SmallCap 100 index slipped 0.07 per cent

Chinese firms' low profit margins face new risks from Trump tariffs

The net profit margins of US listed companies in tradeable goods averaged around 12 per cent last year, more than double the 4.9 per cent of their Chinese peers

Tariff uncertainties may spur rise in third-party pharma manufacturing

Analysts say Indian drugmakers may lean on CDMOs, US plants and diversification to safeguard high-value products as Trump's 100% tariff threat looms over patented drugs

Best of BS Opinion: GST 2.0 reforms miss underlying core principles

Today's pieces look at the available space for more rate cuts, the sorry state of tribunals, why GST reforms are not really that, and how India can harness its vast non-export MSME sector

Beyond the tariff tears: The 99 per cent opportunity in India's MSME engine

The number of exporting MSMEs, despite a commendable trebling in the last four years, was a meagre 173,350 in May last year

US commerce secy calls for India to open mkts, stop actions harming America

Lutnick said that India must open its markets and take actions that would not 'harm' the US

Sun Pharma hit by US tariff risk, but earnings impact to remain limited

The imposition of a 100 per cent tariff by the US on imports of branded and patented pharmaceutical products starting October 1 may not significantly hurt Indian drug makers, with Sun Pharma being exposed to some headline risk but with limited earnings impact, according to analysts. Among Indian companies, only Sun Pharma has sizeable sales from patented drugs in the US (about 17 per cent of 2024-25 revenue), HSBC Global Investment Research said in a report. The US last week announced the imposition of a 100 per cent tariff on branded or patented drugs entering the United States from October 1, except for pharmaceutical companies building manufacturing plants in the US. The exemption covers projects where construction has started, including sites that have broken ground or are under construction. HSBC said Sun Pharma reported global sales of USD 1.217 billion from patented products in FY25, of which the US market accounted for about USD 1.1 billion (85-90 per cent of global sales),

India a country US 'needs to fix': Trump aide Lutnick amid tariff row

US Commerce Secretary Howard Lutnick escalated criticism of India, urging New Delhi to lower tariffs and rethink Russian oil imports as trade tensions with Washington mount